{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:43:28Z","timestamp":1791301408562,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000810","name":"Executive Agency for Health and Consumers","doi-asserted-by":"crossref","award":["2006113"],"award-info":[{"award-number":["2006113"]}],"id":[{"id":"10.13039\/501100000810","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Programma Italia-USA Malattie Rare","award":["526D\/42"],"award-info":[{"award-number":["526D\/42"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.ejca.2012.05.024","type":"journal-article","created":{"date-parts":[[2012,7,5]],"date-time":"2012-07-05T10:17:07Z","timestamp":1341483427000},"page":"3257-3266","source":"Crossref","is-referenced-by-count":167,"title":["Incidence, survival and prevalence of myeloid malignancies in Europe"],"prefix":"10.1016","volume":"48","author":[{"given":"O.","family":"Visser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Trama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maynadi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Stiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Marcos-Gragera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mallone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Tereanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Allemani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Ricardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.C.","family":"Schouten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2012.05.024_b0005","series-title":"World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues","author":"Jaffe","year":"2001"},{"key":"10.1016\/j.ejca.2012.05.024_b0010","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.ejca.2012.05.024_b0015","series-title":"International Classification of Diseases for Oncology (ICD-O). 3rd ed","author":"Percy","year":"2000"},{"key":"10.1016\/j.ejca.2012.05.024_b0020","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM.GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010: http:\/\/globocan.iarc.fr [Accessed on August 2011]."},{"key":"10.1016\/j.ejca.2012.05.024_b0025","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1182\/blood-2010-05-282632","article-title":"Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project","volume":"116","author":"Sant","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2012.05.024_b0030","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.ejca.2011.08.008","article-title":"Rare cancers are not so rare: the rare cancer burden in Europe","volume":"47","author":"Gatta","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2012.05.024_b0035","unstructured":"Ferlay J, Burkhard C, Whelan S, Parkin DM. Check and conversion programs for Cancer Registries. International Agency for Research on Cancer, Technical Report No. 42: Lyon (France); 2005: http:\/\/www.iacr.com.fr\/TR42.htm [Accessed on August 2011]."},{"key":"10.1016\/j.ejca.2012.05.024_b0040","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.ejca.2008.11.003","article-title":"The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis","volume":"45","author":"De Angelis","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2012.05.024_b0045","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/annonc\/mdf152","article-title":"Measuring cancer prevalence in Europe: the EUROPREVAL Project","volume":"13","author":"Capocaccia","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2012.05.024_b0050","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<425::AID-SIM414>3.0.CO;2-Z","article-title":"Estimating the completeness of prevalence based on cancer registry data","volume":"16","author":"Capocaccia","year":"1997","journal-title":"Stat Med"},{"key":"10.1016\/j.ejca.2012.05.024_b0055","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO;2-#","article-title":"An alternative approach to monitoring cancer patient survival","volume":"78","author":"Brenner","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2012.05.024_b0060","unstructured":"Altekruse SF, Kosary CL, Krapcho M, et al., editors. SEER Cancer Statistics Review, 1975\u20132007, National Cancer Institute. Bethesda, MD, based on November 2009 SEER data submission, posted to the SEER web site, 2010. Available from: http:\/\/seer.cancer.gov\/csr\/1975_2007\/ [Accessed on August 2011]."},{"key":"10.1016\/j.ejca.2012.05.024_b0065","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s10552-007-9061-1","article-title":"Occupational exposure to pesticides and risk of hematopoietic cancers: meta-analysis of case\u2013control studies","volume":"18","author":"Merhi","year":"2007","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ejca.2012.05.024_b0070","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1054\/bjoc.2000.1376","article-title":"A pooled analysis of magnetic fields and childhood leukaemia","volume":"83","author":"Ahlbom","year":"2000","journal-title":"British J Cancer"},{"key":"10.1016\/j.ejca.2012.05.024_b0075","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s10552-008-9199-5","article-title":"Childhood hematopoietic malignancies and parental use of tobacco and alcohol: the ESCALE study (SFCE)","volume":"19","author":"Rudant","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ejca.2012.05.024_b0080","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1158\/1055-9965.EPI-09-1110","article-title":"Maternal alcohol consumption during pregnancy and risk of childhood leukemia: systematic review and meta-analysis","volume":"19","author":"Latino-Martel","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejca.2012.05.024_b0085","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1470-2045(00)00435-6","article-title":"Pattern of malignant disorders in individuals with Down\u2019s syndrome","volume":"2","author":"Hasle","year":"2001","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2012.05.024_b0090","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/mpo.1126","article-title":"Therapy-related leukemia associated with alkylating agents","volume":"36","author":"Davies","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.ejca.2012.05.024_b0095","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.leukres.2006.07.002","article-title":"Alcohol consumption and risk of leukemia: a multi center case\u2013control study","volume":"31","author":"Gorini","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.ejca.2012.05.024_b0100","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1158\/1055-9965.EPI-08-1118","article-title":"Sex disparities in cancer incidence by period and age","volume":"18","author":"Cook","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejca.2012.05.024_b0105","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/01.pas.0000131541.95394.23","article-title":"Extranodal histiocytic sarcoma: clinicopathological analysis of 14 cases of a rare epithelioid malignancy","volume":"28","author":"Hornick","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2012.05.024_b0110","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/1947601911408076","article-title":"Genetic abnormalities and challenges in the treatment of acute myeloid leukemia","volume":"2","author":"Kumar","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.ejca.2012.05.024_b0115","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0959-8049(98)00339-6","article-title":"Variation in survival of adult patients with haematological malignancies in Europe since 1978","volume":"34","author":"Carli","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2012.05.024_b0120","doi-asserted-by":"crossref","first-page":"v61","DOI":"10.1093\/annonc\/mdg754","article-title":"EUROCARE-3: survival of cancer patients diagnosed 1990\u201394-results and commentary","volume":"14","author":"Sant","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2012.05.024_b0125","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ejca.2008.11.018","article-title":"EUROCARE Working Group. EUROCARE-4: Survival of cancer patients diagnosed in 1995\u20131999. Results and commentary","volume":"45","author":"Sant","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2012.05.024_b0130","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1182\/blood.V76.9.1704.1704","article-title":"All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results","volume":"76","author":"Castaigne","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2012.05.024_b0135","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","article-title":"The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children\u2019s Leukaemia Working Parties","volume":"92","author":"Grimwade","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2012.05.024_b0140","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1034\/j.1600-0609.2000.90236.x","article-title":"Incidence, clinical features and outcome of essential thrombocythaemia in a well defined geographical area","volume":"65","author":"Jensen","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ejca.2012.05.024_b0145","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.amjmed.2004.06.032","article-title":"Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia","volume":"117","author":"Passamonti","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.ejca.2012.05.024_b0150","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/archinte.165.22.2651","article-title":"Long-term outcome of 231 patients with essential thrombocythemia: prognostic factors for thrombosis, bleeding, myelofibrosis, and leukemia","volume":"165","author":"Chim","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejca.2012.05.024_b0155","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1182\/blood-2011-01-330332","article-title":"Changes in the dynamics of the excess mortality rate in chronic phase-chronic myeloid leukemia over 1990\u20132007: a population study","volume":"118","author":"Corm","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2012.05.024_b0160","first-page":"1400","article-title":"The incidence and outcome of myeloid malignancies in 2112 adult patients in southeast England","volume":"91","author":"Phekoo","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.ejca.2012.05.024_b0165","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/cncr.22570","article-title":"Myelodysplastic syndromes: incidence and survival in the United States","volume":"109","author":"Ma","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2012.05.024_b0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3324\/haematol.2010.026252","article-title":"Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d\u2019Or (Burgundy, France)","volume":"96","author":"Maynadi\u00e9","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.ejca.2012.05.024_b0175","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJMoa061292","article-title":"Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion","volume":"355","author":"List","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2012.05.024_b0180","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(09)70003-8","article-title":"Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study","volume":"10","author":"Fenaux","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2012.05.024_b0185","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/cncr.21792","article-title":"Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study","volume":"106","author":"Kantarjian","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2012.05.024_b0190","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ejca.2008.11.028","article-title":"The cancer survival gap between elderly and middle-aged patients in Europe is widening","volume":"45","author":"Quaglia","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2012.05.024_b0195","series-title":"Prevalence of haematological malignancies in Europe, XXXV","author":"De Angelis","year":"2010"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804912004698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804912004698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T07:50:29Z","timestamp":1594367429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804912004698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":39,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0959804912004698"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2012.05.024","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}